01521.HK
Frontage Holdings Corporation
HKSE · Healthcare · Biotechnology · US
HKD 1.30
−0.38%Margins
Gross margin
26.7%
EBITDA margin
17.4%
EBIT margin
6.5%
Net margin
2.7%
FCF margin
6.1%
4.1%
Return on equity
2.5%
Return on assets
6.9%
Return on invested capital
0.95x
Asset turnover
HKD 344.4M
Cash from operations
HKD 0.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026